Cancer Vaccine Institute (CVI) at UW Medicine
@uwcvi.bsky.social
Igniting the immune system to end cancer, one vaccine at a time. Breast | Ovarian | Lung | Prostate | Bladder | Sarcoma | Lab to Clinical Trials Visit www.uwcvi.org to learn more.
September is Ovarian Cancer Awareness Month. The CVI is exploring how cancer vaccines can program the immune system to treat ovarian cancer, prevent recurrence, and prevent the disease altogether. Read more: www.uwcvi.org/post/ovarian... #OvarianCancer #CancerResearch #CancerVaccines
For over 15 years, Doreen Higgins, Research Nurse, helped clinical trial participants feel informed, supported, and seen at the CVI. Her commitment to patients had a profound impact and remains an invaluable part of the CVI culture. Read Higgins’ story: www.uwcvi.org/post/on-the-...
The first half of 2026 has been an exciting one at the Cancer Vaccine Institute, and we’re proud to share the progress we’ve made in our Midyear Review. Read our latest update here: mailchi.mp/5b9b2540c23d... #CancerResearch #CancerResearch #UWCVI
Congratulations Dr. Nora Disis, CVI Director, who has been selected by @sitcancer.bsky.social to join the 2026 Fellows of the Academy of Immuno-Oncology. Learn more about this award and celebrate with us here: www.uwcvi.org/post/dr-nora... Headshot Credits: Lisa Stromme Warren
Dr. Nora Disis, CVI Director, was featured on OncNow, a podcast by the @emjreviews.com. She talked about the science behind therapeutic and preventive cancer vaccines. Read more here: www.uwcvi.org/post/that-is... #CancerResearch #WomenInSTEM #CancerVaccines
Help us advance the next generation of cancer immunotherapies as a Research Scientist/Engineer 3 for our Immunologic Monitoring Lab. In this role, you’ll develop and execute immunologic assays while supporting cutting-edge cancer research. wd5.myworkdaysite.com/recruiting/u... #SeattleJobs
Meet Dr. Brie Chun, Principal Investigator at the Cancer Vaccine Institute and a breast oncologist at the Fred Hutch Cancer Center. Learn how she's advancing breast cancer research and patient care here: www.uwcvi.org/post/on-the-... #OntheCancerResearchFrontier #WomenInScience #CancerResearch
𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗔𝗰𝘁𝗶𝗼𝗻: 𝗠𝗲𝗲𝘁 𝗡𝗲𝗯𝗶𝘆𝗼𝘂 𝗗𝗮𝗻𝗶𝗲𝗹 🔬 For Nebiyou, cancer research is personal. Now an ACS Post-Bacc Fellow at @uwcvi.bsky.social, he’s turning that passion into purpose—exploring how biology and lived experience shape cancer outcomes. #CanSky #OncoSky 🧪
“Finance, focus, fortitude, and fearlessness.” In a recent @onclive.bsky.social podcast episode, Dr. Nora Disis, Cancer Vaccine Institute Director, reflects on her career journey, cancer vaccine research, and the future of cancer prevention. Read more and listen: www.uwcvi.org/post/onclive...
Long-lasting immunity is key to the success of cancer vaccines. CVI’s Dr. John Liao and Dr. Nora Disis discuss factors that may help predict which patients will develop long-term immunity after vaccination. Read more here: www.uwcvi.org/post/what-ma... #CancerResearch
A new clinical trial reveals that CVI’s WOKVAC cancer vaccine was safe and generated the desired immune response against non-metastatic breast cancer. Read more: www.uwcvi.org/post/wokvac-... #ClinicalTrial #CancerVaccine #CancerResearch
Congresswoman Pramila Jayapal visited the CVI to learn how cancer vaccines could transform treatment, prevent recurrence, and one day stop cancer before it starts. Sustained investment in research is key to making this future possible. Read more here: www.uwcvi.org/post/inside-... #CancerResearch
Dr. Nora Disis, CVI Director, joined the Presidential Select Symposium at the 2026 AACR meeting. From immune-training vaccines to approaches targeting DCIS and obesity-related risk, she shared how CVI is advancing prevention. Read here: www.uwcvi.org/post/dr-nora... #CancerResearch #CancerVaccines
Dr. Kiran Dhillon, CVI Executive Director, joined global leaders at XPRIZE Global Visioneering, tackling humanity’s biggest challenges. She presented a bold prize concept that aligns with the CVI mission: vaccines that prevent and treat cancer. Read more: www.uwcvi.org/post/cvi-lea...
The Lancet Oncology’s article features a $200 million initiative to fund cancer vaccine clinical trials. Dr. Disis, Director of the CVI, called this initiative a promising start. Read more here: www.uwcvi.org/post/a-new-i... #CancerVaccine
Years of dedication and research have brought COLOVAC from concept to reality, making colon cancer prevention more than just a vision. Learn more and donate here to support our work: uwcvi.org/donate-now #CancerVaccine #ColonCancer #EnoughCRC
Dr. Nora Disis, CVI Director, Editor-in-Chief of JAMA Oncology, and Deputy Editor of JAMA, joined Healthcare Unfiltered with Dr. Chadi Nabhan to discuss peer review, impact factors, and how medical evidence is evaluated before publication. Learn more here: www.uwcvi.org/post/team-sc... #Podcast
COLOVAC can help people with high genetic risk, such as FAP, precancerous polyps, or those who have been treated to remission after a colon cancer diagnosis. We anticipate a Phase I clinical trial for COLOVAC to begin within 3 years. Prevention is within reach. #CancerVaccine
Dr. Nora Disis, CVI Director, was featured on KING 5 News to talk about our colon cancer vaccine progress. Read more details: www.uwcvi.org/post/king-5-... Dr. Disis PC: Lisa Stromme Warren #CancerVaccine @uwmnewsroom.bsky.social @uwmedicine.bsky.social @king5news.com.web.brid.gy @nbcnews.com
COLOVAC reduced the number of intestinal and colon polyps in mouse models of colon cancer, promising results in its ability to intercept colon cancer. We are one step closer to a human clinical trial. Read more about COLOVAC here: www.uwcvi.org/post/colon-c... #COLOVAC #UWCVI #CancerVaccine
CVI’s Dr. Natasha (Tasha) Hunter has been named the 2026 Athena Endowed Award recipient for Excellence in Breast Cancer Research. The award honors an early career researcher whose recent work advances breast cancer prevention, detection, diagnosis, or treatment. #WomenInStem PC: Fred Hutch
COLOVAC is designed to target specific proteins that appear at abnormally high levels in precancerous polyps and colorectal tumors. We hope to stop cancer at its earliest stages, long before it becomes life-threatening. #CancerPrevention #COLOVAC
Dr. Kiran Dhillon (CVI Executive Director) co-authored a Viewpoint with Dr. Lennard Lee (University of Oxford) in JAMA Oncology, calling for a renewed commitment to cancer vaccines. We are proud to be at the forefront of the fight against cancer. Read more here: www.uwcvi.org/post/dr-kira...
Imagine a vaccine that teaches the immune system to detect and eliminate the earliest signs of colon cancer. That’s COLOVAC, our colon cancer vaccine in development. It’s changing how we think about cancer prevention. Follow us to learn more. #CancerVaccine #EnoughCRC
Some inherited genetic mutations dramatically increase the likelihood of developing colon cancer, and at younger ages. The CVI is working toward a future where risk doesn’t have to become reality, by advancing vaccines that intercept cancer before it starts. #CancerPrevention #UWCVI
March is Colorectal Cancer Awareness Month. Colorectal cancer is on the rise, and it’s affecting younger adults more than ever before Intercepting cancer early saves lives. Let’s talk about prevention, screening, and care. #ColorectalCancerAwareness #CancerPrevention #EnoughCRC #UWCVI
A recent study showed that our HER2 ICD DNA vaccine, which tells a patient’s cells to create HER2 fragments instead of introducing protein fragments (peptides), demonstrated stronger and more comprehensive immune activation. Read more: www.uwcvi.org/post/dna-bas...
A new clinical trial reveals that CVI’s WOKVAC, a HER2-targeted cancer vaccine, may reduce breast cancer recurrence and doubled HER2-specific immune responses. Read more here: www.uwcvi.org/post/cvi-s-w... #CancerResearch #ClinicalTrial
The Cancer Vaccine Institute is proud to share a year-in-review that highlights the research, achievements, and progress made in 2025. Read our newsletter here: mailchi.mp/f1e9b3bb9637... #CancerResearch #CancerVaccines
